Zobrazeno 1 - 10
of 213
pro vyhledávání: '"Zhiguang Zhou"'
Autor:
Yang Xiao, Yanfei Wang, Jiyoon Ryu, Wei Liu, Hailan Zou, Rong Zhang, Yin Yan, Zhe Dai, Deling Zhang, Lu-Zhe Sun, Feng Liu, Zhiguang Zhou, Lily Q. Dong
Publikováno v:
Diabetologia. 66:1142-1155
Publikováno v:
Obesity Surgery. 33:453-468
This meta-analysis was performed to investigate how cardiac structures and functions change in the very early stage after bariatric surgery.We thoroughly searched the PubMed, Embase, Cochrane Library, and Web of Science databases for articles includi
Autor:
Leweihua, Lin, Huibiao, Quan, Tuanyu, Fang, Lu, Lin, Qianying, Ou, Huachuan, Zhang, Kaining, Chen, Zhiguang, Zhou
Publikováno v:
Endokrynologia Polska. 73:856-862
Fasting proinsulin (FPI) and fasting insulin (FI) have been demonstrated to be associated with impaired b cell function, T2DM, and insulin resistance. This genome-wide association study (GWAS) was performed to contribute to our understanding of the g
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1901-1911
Type 1 diabetes (T1D) is a complex autoimmune disease characterized by an absolute deficiency of insulin. It affects more than 20 million people worldwide and imposes an enormous financial burden on patients. The underlying pathogenic mechanisms of T
Autor:
Yimeng Wang, Ying Xia, Yan Chen, Linling Xu, Xiaoxiao Sun, Jiaqi Li, Gan Huang, Xia Li, Zhiguo Xie, Zhiguang Zhou
Publikováno v:
Frontiers in Endocrinology. 14
BackgroundTo a great extent, genetic factors contribute to the susceptibility to type 1 diabetes (T1D) development, and by triggering immune imbalance, Toll-like receptor (TLR) 9 is involved in the development of T1D. However, there is a lack of evid
Publikováno v:
Diabetes/Metabolism Research and Reviews.
Autor:
Zhijie Dai, Ronghua Zhu, Zhifeng Sheng, Guijun Qin, Xianghang Luo, Qun Qin, Chunli Song, Liping Li, Ping Jin, Guoping Yang, Yanxiang Cheng, Danhong Peng, Chong Zou, Lijuan Wang, Jianzhong Shentu, Qin Zhang, Zhe Zhang, Xiang Yan, Pingfei Fang, Qiangyong Yan, Lingfeng Yang, Xiao Fan, Wei Liu, Bo Wu, Rongrong Cui, Xiyu Wu, Yuting Xie, Chang Shu, Kai Shen, Wenhua Wei, Wei Lu, Hong Chen, Zhiguang Zhou
Publikováno v:
Frontiers in Endocrinology. 14
SHR-1222, a novel humanized monoclonal antibody targeting sclerostin, has been shown to induce bone formation and decrease bone resorption at a single dose ranging 50–400 mg in our previous phase 1 trial. This study was a randomized, double-blind,
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Context Diabetes is a major health problem and metabolically unhealthy is an important risk factor. Objective To conduct the first nationally representative study on epidemiological data of metabolically unhealthy normal weight (MUNW) focused only on
Publikováno v:
Pediatric Diabetes. 23:578-587
To investigate the prevalence and clinical features of latent autoimmune diabetes in youth (LADY) diagnosed between 15 and 29 years old as a component of an age-related autoimmune diabetes spectrum.This nationwide, multicenter, cross-sectional study
Publikováno v:
Diabetes Therapy. 13:1161-1174